Search

Technology developers at Ghent University developed a spin freeze-drying process for continuous processing.

Could nucleic acid medicines be the solution to the complex problems associated with advanced therapy manufacture?

It’s been a busy start to the year for biopharma, with a plethora of new announcements.

What can the advanced therapy sector learn from COVID-19 vaccine development?

What happened in May in the biopharma industry? Here’s our roundup of the biggest headlines.

Pharma experts discuss the most exciting industry breakthroughs in recent years

How will vaccine and therapeutic makers respond to the new SARS-CoV-2 variant?

The COVID-19 pandemic has helped propel the RNA field forward, but manufacturing and funding challenges lie ahead.

The International Vaccine Institute is working to make a difference for vaccine manufacture in the world’s less wealthy regions

A typical vaccine takes around 10 to 12 years to reach the market. A key question: “Where should we base production?”